Imatinib/nilotinib

Multisystem toxicities: 2 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Gurianova MA, et al. [Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review]. Terapevticheskii Arkhiv 92: 90-94, No. 7, Sep 2020. Available from: URL: http://doi.org/10.26442/00403660.2020.07.000789 [Russian; summarised from a translation]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Imatinib/nilotinib. Reactions Weekly 1842, 207 (2021). https://doi.org/10.1007/s40278-021-90943-3

    Download citation